United States
Germany
Japan
United Kingdom
China
PLA2G3 mouse monoclonal antibody,clone OTI8G8
| Applications | WB |
| Reactivities | Human |
Antibodies
PLA2G3 mouse monoclonal antibody,clone OTI1F4
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI4F2
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI8G8, Biotinylated
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI4F2, Biotinylated
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI1F4, Biotinylated
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI4F2, HRP conjugated
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI8G8, HRP conjugated
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI1F4, HRP conjugated
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) PLA2G3 mouse monoclonal antibody,clone OTI8G8
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) PLA2G3 mouse monoclonal antibody,clone OTI1F4
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) PLA2G3 mouse monoclonal antibody,clone OTI4F2
| Applications | WB |
| Reactivities | Human |
Rabbit polyclonal antibody to PLA2G3 (phospholipase A2, group III)
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI4F2
| Applications | WB |
| Reactivities | Human |
PLA2G3 mouse monoclonal antibody,clone OTI8G8
| Applications | WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Conjugates
Modifications
Clonalities
Brands
Pathways
- Arachidonic acid metabolism (17)
- Ether lipid metabolism (17)
- Fc epsilon RI signaling pathway (17)
- Glycerophospholipid metabolism (17)
- GnRH signaling pathway (17)
- Linoleic acid metabolism (17)
- Long-term depression (17)
- MAPK signaling pathway (17)
- Metabolic pathways (17)
- VEGF signaling pathway (17)
- Vascular smooth muscle contraction (17)
- alpha-Linolenic acid metabolism (17)
